Stay updated on Gem/Benda/Nivo Combo in Relapsed Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Gem/Benda/Nivo Combo in Relapsed Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Gem/Benda/Nivo Combo in Relapsed Hodgkin Lymphoma Clinical Trial page
- Check2 days agoChange DetectedAdded a Locations section with Georgia as a site, removed the old Georgia Locations label and the HHS Vulnerability Disclosure, and updated the page revision to v3.3.3.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedThe page revision was updated from v3.2.0 to v3.3.2 as a minor maintenance update that does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check38 days agoChange DetectedRemoved the government funding status notice from the page. The notice previously informed users about potential delays and linked to cc.nih.gov and opm.gov for operating status updates.SummaryDifference0.4%

- Check52 days agoChange DetectedNo significant changes in core study content were detected; the screenshots show only minor UI/layout differences with no edits to the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedUpdated the page to v3.2.0 and added a prominent government status notice about funding and operating status; removed the old v3.1.0 reference. This signals a maintenance/update of the page and current operating information.SummaryDifference3%

- Check88 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

Stay in the know with updates to Gem/Benda/Nivo Combo in Relapsed Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gem/Benda/Nivo Combo in Relapsed Hodgkin Lymphoma Clinical Trial page.